TRITON SYSTEMS, INC. - DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG

On Feb 4, 2026, Department of Health and Human Services obligated $3,191,607 to TRITON SYSTEMS, INC. for development of digital satiorx, a very low cost remotely controllable disposable microneedle transdermal drug delivery device able to deliver any liquid fda approved transdermal drug. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 3 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in CHELMSFORD, MA.